Guffroy C, Strolin Benedetti M
Life Sci. 1984 Feb 6;34(6):535-45. doi: 10.1016/0024-3205(84)90486-7.
The aim of the present work was to compare monoamine oxidase (MAO) and semicarbazide sensitive amine oxidase (SSAO) activity in several tissues from spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto rats (WKY). Contribution of MAO-A, -B and SSAO to the metabolism of each substrate in each tissue was defined from experiments where the decrease of oxidative deamination of each substrate at a given concentration was measured as a function of increasing concentrations of a selective MAO-A, -B or SSAO inhibitor. In the heart, aorta and, to a lesser extent, the femoral arteries MAO-A activity was higher in SHR than in WKY. Similarly in the liver the enzyme activity was higher in SHR than in WKY but was due to the -B form of MAO. In all the other tissues studied (duodenum, brain, lungs, adrenals and kidneys) no difference in MAO-A, MAO-B or SSAO activity was found between SHR and WKY, except for the kidneys and brain, if the differences in the weights of these organs in SHR are taken into account.
本研究的目的是比较自发性高血压大鼠(SHR)和正常血压的Wistar-Kyoto大鼠(WKY)几种组织中的单胺氧化酶(MAO)和氨基脲敏感性胺氧化酶(SSAO)活性。通过实验确定MAO-A、-B和SSAO对各组织中每种底物代谢的贡献,在这些实验中,在给定浓度下,每种底物氧化脱氨作用的降低作为选择性MAO-A、-B或SSAO抑制剂浓度增加的函数进行测量。在心脏、主动脉以及程度稍轻的股动脉中,SHR的MAO-A活性高于WKY。同样,在肝脏中,SHR的酶活性高于WKY,但这是由于MAO的-B形式。在所有其他研究组织(十二指肠、脑、肺、肾上腺和肾脏)中,SHR和WKY之间未发现MAO-A、MAO-B或SSAO活性存在差异,但如果考虑到SHR中这些器官重量的差异,则肾脏和脑除外。